TCM
UTHR icon

Twin Capital Management’s United Therapeutics UTHR Stock Holding History

Twin Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
+2,643
New +$1.49M 0.16% 134
2019
Q2 		– Sell
-31,540
Closed -$3.7M – 285
2019
Q1 		$3.7M Buy
31,540
+90
+0.3% +$10.5K 0.18% 160
2018
Q4 		$3.42M Sell
31,450
-580
-2% -$67.3K 0.19% 149
2018
Q3 		$4.1M Buy
32,030
+2,350
+8% +$291K 0.19% 146
2018
Q2 		$3.36M Buy
29,680
+190
+0.6% +$20.9K 0.17% 166
2018
Q1 		$3.31M Sell
29,490
-2,000
-6% -$254K 0.17% 162
2017
Q4 		$4.66M Buy
31,490
+1,150
+4% +$146K 0.23% 125
2017
Q3 		$3.56M Buy
30,340
+5,310
+21% +$678K 0.19% 165
2017
Q2 		$3.25M Sell
25,030
-18,626
-43% -$2.32M 0.19% 160
2017
Q1 		$5.91M Buy
43,656
+15,308
+54% +$2.32M 0.37% 84
2016
Q4 		$4.07M Buy
28,348
+22,798
+411% +$2.91M 0.26% 116
2016
Q3 		$655K Sell
5,550
-6,826
-55% -$820K 0.04% 300
2016
Q2 		$1.31M Buy
+12,376
New +$1.38M 0.1% 279
2015
Q2 		– Sell
-15,640
Closed -$2.7M – 266
2015
Q1 		$2.7M Buy
15,640
+3,850
+33% +$587K 0.24% 132
2014
Q4 		$1.53M Buy
11,790
+2,250
+24% +$290K 0.15% 174
2014
Q3 		$1.23M Buy
9,540
+600
+7% +$61.9K 0.12% 185
2014
Q2 		$791K Sell
8,940
-1,550
-15% -$149K 0.08% 224
2014
Q1 		$986K Sell
10,490
-1,460
-12% -$149K 0.1% 214
2013
Q4 		$1.35M Sell
11,950
-4,800
-29% -$433K 0.14% 183
2013
Q3 		$1.32M Sell
16,750
-6,200
-27% -$453K 0.14% 201
2013
Q2 		$1.51M Buy
+22,950
New +$1.48M 0.16% 166

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Twin Capital Management's UTHR Position: Q2 2026 in Review

Twin Capital Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,643 shares worth $1.43M. The stake represents 0.16% of the portfolio and ranks #134 among its holdings. This is a return to the name: Twin Capital Management previously reported a position in UTHR as recently as Q1 2019.

Twin Capital Management first reported a position in UTHR in Q2 2013 and has held it in 21 quarters since. The position peaked at $5.91M in Q1 2017. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Twin Capital Management held 2,643 shares of United Therapeutics worth $1.43M as of Q2 2026.
  • United Therapeutics was a new Twin Capital Management position in Q2 2026.
  • United Therapeutics made up 0.16% of Twin Capital Management's portfolio in Q2 2026, its #134 holding.
  • Twin Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 21 quarters since.
  • Twin Capital Management's United Therapeutics position peaked at $5.91M in Q1 2017.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Twin Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.